Publications by authors named "Rudolf Prager"

Claim this Profile
[
[Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2023)].
Martin Clodi, Heidemarie Abrahamian, Helmut Brath, Guntram Schernthaner, Johann Brix, Rudolf Prager

Wien Klin Wochenschr· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Injection therapy of diabetes].
Monika Lechleitner, Michael Roden, Raimund Weitgasser, Bernhard Ludvik, Peter Fasching, Rudolf Prager

Wien Klin Wochenschr· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Diagnosis and insulin therapy of type 1 diabetes mellitus (Update 2023)].
Monika Lechleitner, Susanne Kaser, Friedrich Hoppichler, Michael Roden, Raimund Weitgasser, Rudolf Prager

Wien Klin Wochenschr· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and tolerability of alirocumab in Austrian clinical practice - results of the non-interventional PEARL-AT study.
Deborah R Leitner, Hermann Toplak, Ludmilla Kedenko, Thomas Steinmaurer, Verena Gräff, Rudolf Prager

Curr Med Res Opin· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Diabetic kidney disease (Update 2019) : Position paper of the Austrian Diabetes Association and the Austrian Society for Nephrology].
Harald Sourij, Roland Edlinger, Friedrich C Prischl, Martin Auinger, Susanne Kaser, Rudolf Prager

Wien Klin Wochenschr· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Diagnosis and insulin therapy of type 1 diabetes mellitus (Update 2019)].
Monika Lechleitner, Susanne Kaser, Friedrich Hoppichler, Michael Roden, Raimund Weitgasser, Rudolf Prager

Wien Klin Wochenschr· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Insulin therapy of type 2 diabetes mellitus (Update 2019)].
Monika Lechleitner, Martin Clodi, Heidemarie Abrahamian, Helmut Brath, Johanna Brix, Rudolf Prager

Wien Klin Wochenschr· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2019)].
Martin Clodi, Heidemarie Abrahamian, Helmut Brath, Johanna Brix, Heinz Drexel, Rudolf Prager

Wien Klin Wochenschr· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use and effectiveness of a fixed-ratio combination of insulin degludec/liraglutide (IDegLira) in a real-world population with type 2 diabetes: Results from a European, multicentre, retrospective chart review study.
Hermione Price, Matthias Blüher, Rudolf Prager, Tra-Mi Phan, Brian L Thorsted

Diabetes Obes Metab· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A European, multicentre, retrospective, non-interventional study (EU-TREAT) of the effectiveness of insulin degludec after switching basal insulin in a population with type 1 or type 2 diabetes.
Thorsten Siegmund, Nikolaos Tentolouris, Søren T Knudsen, Annunziata Lapolla, Rudolf Prager

Diabetes Obes Metab· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of IDegLira titrated once weekly versus twice weekly in patients with type 2 diabetes uncontrolled on oral antidiabetic drugs: DUAL VI randomized clinical trial.
Stewart B Harris, Győző Kocsis, Rudolf Prager, Terry Ridge, Keval Chandarana

Diabetes Obes Metab· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GDF-15 Is Associated with Cancer Incidence in Patients with Type 2 Diabetes.
Noemi Pavo, Raphael Wurm, Stephanie Neuhold, Christopher Adlbrecht, Greisa Vila, Rudolf Prager

Clin Chem· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular safety of metformin and sulfonylureas in patients with different cardiac risk profiles.
Raphael Wurm, Michael Resl, Stephanie Neuhold, Rudolf Prager, Helmut Brath

Heart· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Type 2 Diabetes mellitus-screening and prevention: Update 2016].
Marietta Stadler, Elke Fröhlich-Reiterer, Rudolf Prager

Wien Klin Wochenschr· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Insulin therapy of diabetes].
Monika Lechleitner, Michael Roden, Raimund Weitgasser, Bernhard Ludvik, Peter Fasching, Rudolf Prager

Wien Klin Wochenschr· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Diabetic kidney disease - Update 2016].
Harald Sourij, Roland Edlinger, Friedrich Prischl, Martin Auinger, Alexandra Kautzky-Willer, Rudolf Prager

Wien Klin Wochenschr· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[CGM-Continuous Glucose Monitoring--Statement of the Austrian Diabetes Association].
Ingrid Schütz-Fuhrmann, Birgit Rami-Merhar, Sabine Hofer, Marietta Stadler, Martin Bischof, Rudolf Prager

Wien Klin Wochenschr· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Insulin pump therapy in children, adolescents and adults].
Marietta Stadler, Sandra Zlamal-Fortunat, Ingrid Schütz-Fuhrmann, Birgit Rami-Merhar, Elke Fröhlich-Reiterer, Rudolf Prager

Wien Klin Wochenschr· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Antihyperglycemic treatment guidelines for diabetes mellitus type 2].
Martin Clodi, Heidemarie Abrahamian, Heinz Drexel, Peter Fasching, Bernhard Föger, Rudolf Prager

Wien Klin Wochenschr· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and tolerability of vildagliptin-based versus comparative dual therapy in type 2 diabetes : Results of the Austrian subpopulation of the EDGE study.
Helmut Brath, Christoph Bialek, Ewald Gingl, Michael Resl, Rudolf Prager

Wien Klin Wochenschr· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mortality and incidence of renal replacement therapy in people with type 1 diabetes mellitus--a three decade long prospective observational study in the Lainz T1DM cohort.
Marietta Stadler, Slobodan Peric, Hermine Strohner-Kaestenbauer, Reinhard Kramar, Thomas Kaestenbauer, Rudolf Prager

J Clin Endocrinol Metab· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of smoking cessation on β-cell function, insulin sensitivity, body weight, and appetite.
Marietta Stadler, Larissa Tomann, Angela Storka, Michael Wolzt, Slobodan Peric, Rudolf Prager

Eur J Endocrinol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are there differences in LDL-C target value attainment in Austrian federal states? Yes!
Max Pichler, Dominik Lautsch, Claudia Adler, Karl Bögl, Heinz Drexel, Rudolf Prager

Wien Med Wochenschr· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PONTIAC (NT-proBNP selected prevention of cardiac events in a population of diabetic patients without a history of cardiac disease): a prospective randomized controlled trial.
Martin Huelsmann, Stephanie Neuhold, Michael Resl, Guido Strunk, Helmut Brath, Rudolf Prager

J Am Coll Cardiol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimated glomerular filtration rate and albuminuria: true predictors of cardiovascular events in obese patients with type 2 diabetes?
Michael Resl, Greisa Vila, Roland Kraxner, Richard Pacher, Anton Luger, Rudolf Prager

Wien Klin Wochenschr· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis